CalciMedica, Inc. (CALC)
NASDAQ: CALC · Real-Time Price · USD
2.150
+0.030 (1.42%)
Sep 11, 2026, 10:40 AM EDT - Market open

CalciMedica Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
15954816--
Market Cap Growth
-66.00%98.97%193.54%---
Enterprise Value
590332--
Last Close Price
2.1232.9517.7014.30--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
2.36-14.303.311.99--
P/TBV Ratio
2.63-3.311.99--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
1.67-1.46----0.10
Net Debt / Equity Ratio
-1.710.50-1.30-1.380.142.38
Net Debt / EBITDA Ratio
0.480.140.770.520.090.21
Net Debt / FCF Ratio
0.490.160.880.440.110.22
Quick Ratio
5.333.445.072.790.281.22
Current Ratio
5.583.585.342.880.361.26
Return on Equity (ROE)
-365.70%-761.02%-121.42%---
Return on Assets (ROA)
-63.58%-86.57%-94.61%-176.03%-180.79%-220.50%
Return on Capital Employed (ROCE)
-122.60%-235.70%-150.20%-268.20%991.80%-846.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-146.73%-31.13%-28.71%-211.31%--
FCF Yield
-132.08%-22.33%-44.32%-158.73%--
Buyback Yield / Dilution
-19.98%-33.48%-150.68%-5354.75%96.97%-3.08%
SEC Filings: 10-K · 10-Q